Zotefoams plc Strong portfolio of products delivers another record year

Zotefoams Plc

Zotefoams plc (LON: ZTF), a world leader in cellular material technology, today announced its unaudited preliminary results for the twelve months ended 31 December 2018.

Significant financial progress during the year

· 16% increase in Group revenue (17% constant currency) to a record £81.04m (2017: £70.15m)

· 23% increase in reported profit before tax and exceptional item to a record £10.81m (2017: £8.81m)

· 31% increase in reported profit before tax to £9.86m (2017: £7.55m)

· 29% increase in EBITDA before exceptional item to £16.66m (2017: £12.87m)

· 35% increase in EBITDA to £15.71m (2017: £11.61m)

· 16% increase in basic EPS before exceptional item to 18.66p (2017: 16.04p)

· 24% increase in basic EPS to 16.96p (2017: 13.70p)

Successful strategic execution

· High-Performance Products now accounts for 27% of Group revenue (2017: 19%) following a 67% increase in sales mainly from footwear and aviation applications

· Core AZOTE® foams business grew by 8% while MuCell Extrusion refocused for expected return to growth in 2019

· Kentucky, USA facility commissioned in March 2018, adding approximately 20% to Group capacity

· Capacity increases on schedule for commissioning in UK and USA during 2019 and at a new site in Poland during 2020

· Successful bank refinancing and equity raise in May 2018 to support growth plans

Commenting on the results, David Stirling, Zotefoams plc Group CEO, said:

“We are seeing the benefits of Zotefoams’ strong portfolio of products, backed by unique technology, across multiple sectors and geographies. 2018 was another record year for Zotefoams and I’m delighted with both the performance and opportunities we are creating.

We have experienced a strong start to the year, consistent with our growth expectations across the business as a whole. Investments in recent years in our product portfolio, people and productive capacity have positioned Zotefoams for further growth. Whilst we appear to be in a generally less favourable macroeconomic environment than in 2018, with volatile foreign exchange rates, the Board remains confident about the future prospects for our business and is excited by the opportunities we see for continued progress.”

The preliminary results presentation for the year ended 31 December 2018 will be made available on the investors section of the Company’s website during the day.

Share on:

Latest Company News

Zotefoams adds sales leadership to support growth targets

Zotefoams has strengthened its EMEA and North American sales teams as it targets higher revenue and operating profit by FY29.

Zotefoams outlines 2025 financial performance and sets 2026 AGM

Zotefoams plc has released its 2025 Annual Report, detailing full-year financial performance and management commentary, including reviews from the Chair, Group CEO and CFO.

Zotefoams reports record FY2025 profits and margin growth

Zotefoams plc posted record revenue of £158.5m and a 26% rise in adjusted operating profit to £22.8m for FY2025, supported by strong cash generation and strategic investment.

Zotefoams reports record profits and 7.2% revenue growth for FY2025

Zotefoams expects full-year revenue of £158.5m for the year ended 31 December 2025, up 7.2% year on year and ahead of market expectations.

Zotefoams delivers consistent Q3 performance and strategic progress

Zotefoams maintained positive trading momentum through Q3 2025, reporting revenue of £38.2 million, aligned with Board expectations and comparable to a strong prior year.

Zotefoams appoints Jack Clarke as Independent Non-Executive Director and incoming Audit Chair

Zotefoams has appointed Jack Clarke as an independent Non-Executive Director effective 28 October 2025. Clarke, formerly CFO of Essentra and Marshalls, brings extensive strategy and finance experience and will join the Audit, Nomination and Remuneration Committees.

    Search